Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Renal Insufficiency, Chronic × perflutren × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 6 Carcinoma, Hepatocellular 5 Prostatic Neoplasms 3 Liver Neoplasms 3 Kidney Neoplasms 3 Thyroid Neoplasms 1 Sleep Apnea, Obstructive 1 Sarcoma 1 Rhinitis, Allergic, Seasonal 1 Renal Insufficiency, Chronic 1 Pulmonary Fibrosis 1 Pulmonary Embolism 1 Pulmonary Disease, Chronic Obstructive 1 Ovarian Neoplasms 1 Mesothelioma 1 Melanoma 1 Lung Neoplasms 1 Lung Diseases, Interstitial 1 Hypertension, Pulmonary 1 Emphysema 1 Cystic Fibrosis 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Intraductal, Noninfiltrating 1 Bronchiectasis 1 Asthma 1 Asbestosis 1 Anatomic Stage III Breast Cancer AJCC v8 1

Interventions

venetoclax 1 saponin QA-21V1 1 perflutren 1 peginesatide 1 hematide 1 finerenone 1 empagliflozin 1 Thalidomide 1 Stem Cell Transplantation 1 Standard of Care 1 Specimen Handling 1 Simethicone 1 Rocuronium 1 Quillaja Saponins 1 Protein Subunit Vaccines 1 Practice Guidelines as Topic 1 Kidney Transplantation 1 Hypothermia, Induced 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Eplerenone 1 Dexamethasone 1 DM199 1 Citric Acid 1 Cholecalciferol 1 Bortezomib 1 Blood Specimen Collection 1 Bendamustine Hydrochloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03907657 2024-05-21

CEUS-VHL

UNC Lineberger Comprehensive Cancer Center

Phase 2 Completed

15 enrolled 7 charts

Renal Insufficiency, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡